Clinical Observation on Qingjin Kangdu Beverage Combined with Western Medicine for 40 Cases of Viral Myocarditis

GU Gang; BAI Mingang; ZHANG Guiying; JI Guangcheng; SHI Yonggui

doi:10.13288/j.11-2166/r.2012.21.027

您当前的位置：

首页 >

文章列表页 >

Clinical Observation on Qingjin Kangdu Beverage Combined with Western Medicine for 40 Cases of Viral Myocarditis

更新时间：2021-11-17

- Clinical Observation on Qingjin Kangdu Beverage Combined with Western Medicine for 40 Cases of Viral Myocarditis
- Journal of Traditional Chinese Medicine Vol. 53, Issue 21, Pages: 1841-1843(2012)
- 作者机构：
  
  威海市中医院心脑科
- 作者简介：
- 基金信息：
- DOI：10.13288/j.11-2166/r.2012.21.027
  CLC： R542.21
- Published：2012
- 稿件说明：
移动端阅览
[1]谷刚,白民刚,张桂英,汲广成,石永贵.青金抗毒饮联合西药治疗病毒性心肌炎40例临床观察[J].中医杂志,2012,53(21):1841-1843.

GU Gang, BAI Mingang, ZHANG Guiying, et al. Clinical Observation on Qingjin Kangdu Beverage Combined with Western Medicine for 40 Cases of Viral Myocarditis[J]. Journal of Traditional Chinese Medicine2012, 53(21): 1841-1843.
[1]谷刚,白民刚,张桂英,汲广成,石永贵.青金抗毒饮联合西药治疗病毒性心肌炎40例临床观察[J].中医杂志,2012,53(21):1841-1843. DOI： 10.13288/j.11-2166/r.2012.21.027.

GU Gang, BAI Mingang, ZHANG Guiying, et al. Clinical Observation on Qingjin Kangdu Beverage Combined with Western Medicine for 40 Cases of Viral Myocarditis[J]. Journal of Traditional Chinese Medicine2012, 53(21): 1841-1843. DOI： 10.13288/j.11-2166/r.2012.21.027.

摘要

目的观察青金抗毒饮治疗病毒性心肌炎的临床疗效。方法将80例病毒性心肌炎患者随机分为治疗组与对照组各40例

对照组给予西医常规治疗;治疗组在常规西医治疗的基础上

口服青金抗毒饮

两组均以4周为1个疗程。于治疗前后进行心功能（心率、心输出量、心搏量、射血分数、心脏指数）及心肌酶谱（乳酸脱氢酶、肌酸激酶、肌酸激酶同工酶）检测

并观察临床疗效及心电图疗效。结果治疗组临床疗效总有效率为92.50%

对照组总有效率为80.00%

治疗组临床疗效优于对照组（P<0.05）。治疗组心电图疗效总有效率为92.50%

对照组总有效率为85.00%

治疗组心电图疗效优于对照组（P<0.05）。两组治疗后心功能及心肌酶谱各项指标较治疗前均明显好转

差异有统计学意义（P<0.05）

且治疗后治疗组各指标优于对照组（P<0.05）。结论青金抗毒饮治疗病毒性心肌炎临床疗效肯定

能改善患者心功能及心肌酶谱。

Abstract

Objective To observe the therapeutic effect of Qingjin Kangdu Beverage [ antitoxic beverage of Qinghao （ Herba Artemisiae Annuae ） and Jinyinhua （ Flos Lonicerae Japonicae ）] on viral myocarditis （ VM ） .Methods Eighty patients with VM were randomized into treatment group and control group

with 40in each.The control group was given conventional thera- py and the treatment group was added with self-made Qingjin Kangdu Beverage.One treatment course lasted for 4weeks.The heart rate （ HR ）

cardiac output （ CO ）

stroke volume （ SV ）

ejection fraction （ EF ）

cardiac index （ CI ）

the efficacy of elec- trocardiogram （ ECG ）

lactate dehydrogenase （ LDH ）

creatine kinase （ CK ）

creatine kinase isoenzyme （ CK-MB ） and clinical efficacy were observed.Results The total effective rate of the treatment group and the control group was 92.50% and 80.00%

respectively.There was significant difference in the therapeutic efficacy between groups （ P<0.05 ） .The total effec- tive rate of ECG efficacy of the treatment group and the control group was 92.50%and 85.00%

respectively.There was sig- nificant difference in the ECG efficacy between groups （ P<0.05 ） .The CO

LDH

CK and CK-MB signifi- cantly improved in both groups after treatment （ P<0.05 ）

especially in the treatment group （ P<0.05 ） .Conclusion Qingjin Kangdu Beverage is effective for VM.

关键词

Keywords

references

查看原文

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Effect of Optimized New Shengmai Powder （优化新生脉散方） on Exercise Tolerance in Patients with Chronic Heart Failure of Qi Deficiency，Blood Stasis and Fluid Retention Syndrome：A Randomized，Double-Blind，Placebo-Controlled Trial

Effect of Yang-Reinforcing and Blood-Activating Therapy on the Long-Term Prognosis for Dilated Cardio-myopathy Patients with Yang Deficiency and Blood Stasis Syndrome：A Retrospective Cohort Study

Qingxin Jieyu Granule （清心解瘀颗粒） for the Treatment of Acute Coronary Syndrome with Binding of Stasis and Toxin Syndrome：A Multicenter，Double-Blind，Placebo Randomize-Controlled Trial

Clinical Observation Adjuvant Treatment with Modified Taohong Siwu Decoction （桃红四物汤） for Patients of Chronic Heart Failure Complicated with Lower Limb Deep Vein Thrombosis in the Chronic Stage of Blood Stasis Syndrome：A Randomize Controlled Clinical Trial

The Effect of Yiqi Huoxue Formula （益气活血方） in the Treatment of Chronic Pulmonary Heart Disease and Heart Failure with Qi Deficiency and Blood Stasis Pattern of 58 Cases： A Randomized Controlled Trial

Related Author

WANG Xianliang

ZHANG Jingyi

GE Zhao

LIU Tongzuo

ZHANG Maozhe

WANG Shuai

ZHAO Zhiqiang

BI Yingfei

Related Institution

Tianjin University of Traditional Chinese Medicine

First Teaching Hospital of Tianjin University of Traditional Chinese Medicine/ National Clinical Research Center for Chinese Medicine

Guang'anmen Hospital，China Academy of Chinese Medical Sciences

Beijing University of Chinese Medicine

Eye Hospital，China Academy of Chinese Medical Sciences

Address：No.16, Nanxiao street, Dongzhimen, Dongcheng District, Beijing Postal code：100700
Tel：010-64035632 Email：jtcmcn@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备09064830号-19 京公网安备11010102007558号
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰